HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-6.99%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.69B
AUM Growth
+$1.69B
(+2.5%)
Cap. Flow
+$191M
Cap. Flow
% of AUM
11.32%
Top 10 Holdings %
Top 10 Hldgs %
60.09%
Holding
55
New
12
Increased
19
Reduced
5
Closed
17
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$94.7M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$90.4M |
| 3 |
DexCom
DXCM
|
$69.6M |
| 4 |
HCA Healthcare
HCA
|
$65.5M |
| 5 |
Edwards Lifesciences
EW
|
$64.3M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$112M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$105M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$89.2M |
| 4 |
Abbott
ABT
|
$74.5M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$59.4M |
Sector Composition
| 1 | Healthcare | 81.78% |
| 2 | Financials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$96B
| $19.9M | 1.13% |
+311,710
| New | +$19.9M |
|
|
ALXN
27
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $19.9M | 1.13% |
142,920
+83,030
| +139% | +$11.6M |
|
|
CVRS
28
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $19.8M | 1.12% |
19,981,655
| – | – |
|
|
SYNH
29
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $19.6M | 1.11% |
+475,000
| New | +$19.6M |
|
|
CELG
30
DELISTED
Celgene Corp
CELG
| $15.6M | 0.88% |
+155,660
| New | +$15.6M |
|
31
Cencora
COR
$56.5B
| $14.8M | 0.84% |
171,240
-287,900
| -63% | -$24.9M |
|
32
McKesson
MCK
$85.4B
| $12M | 0.68% |
+76,150
| New | +$12M |
|
33
Arbutus Biopharma
ABUS
$711M
| $9.21M | 0.52% |
2,229,300
+40,100
| +2% | +$166K |
|
|
SPNE
34
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $9.01M | 0.51% |
615,100
+11,100
| +2% | +$163K |
|
35
Acadia Pharmaceuticals
ACAD
$4.38B
| $5.59M | 0.32% |
200,000
-386,564
| -66% | -$10.8M |
|
36
Natera
NTRA
$23.1B
| $2.73M | 0.15% |
286,800
+11,800
| +4% | +$112K |
|
|
HSTO
37
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.24M | 0.13% |
1,045,700
+18,800
| +2% | +$40.2K |
|
38
AbbVie
ABBV
$372B
| – | – |
-188,600
| Closed | -$11.2M |
|
|
39
Abbott
ABT
$231B
| – | – |
-1,658,540
| Closed | -$74.5M |
|
40
Align Technology
ALGN
$10.3B
| – | – |
-8,000
| Closed | -$527K |
|
41
Amgen
AMGN
$155B
| – | – |
-2,250
| Closed | -$365K |
|
42
Biogen
BIIB
$19.4B
| – | – |
-47,090
| Closed | -$14.4M |
|
43
Brookdale Senior Living
BKD
$1.83B
| – | – |
-2,500,000
| Closed | -$46.2M |
|
44
Incyte
INCY
$16.5B
| – | – |
-322,030
| Closed | -$34.9M |
|
45
iShares Russell 2000 ETF
IWM
$67B
| – | – |
0
| – | – |
|
|
46
Eli Lilly
LLY
$657B
| – | – |
-1,325,000
| Closed | -$112M |
|
47
Merck
MRK
$210B
| – | – |
-235,440
| Closed | -$12.4M |
|
48
Pacira BioSciences
PCRX
$1.2B
| – | – |
-21,500
| Closed | -$1.65M |
|
49
Tandem Diabetes Care
TNDM
$845M
| – | – |
-195,112
| Closed | -$2.3M |
|
50
UnitedHealth
UNH
$281B
| – | – |
-8,150
| Closed | -$959K |
|